PA8486601A1 - Formulaciones antiparasitos - Google Patents

Formulaciones antiparasitos

Info

Publication number
PA8486601A1
PA8486601A1 PA19998486601A PA8486601A PA8486601A1 PA 8486601 A1 PA8486601 A1 PA 8486601A1 PA 19998486601 A PA19998486601 A PA 19998486601A PA 8486601 A PA8486601 A PA 8486601A PA 8486601 A1 PA8486601 A1 PA 8486601A1
Authority
PA
Panama
Prior art keywords
antiparasite
formulations
doramectin
injection
action
Prior art date
Application number
PA19998486601A
Other languages
English (en)
Inventor
Valerie Denise Harding
Stephen Richard Wicks
Timothy Michael Lukask
Snezana Milojevic
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PA8486601A1 publication Critical patent/PA8486601A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Abstract

SE DESCRIBE EN LA PRESENTE FORMULACIONES ANTIPARÁSITOS DE ACCIÓN DE DORAMECTINA, ADECUADAS PARA INYECCIÓN
PA19998486601A 1998-12-16 1999-12-07 Formulaciones antiparasitos PA8486601A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9827727.0A GB9827727D0 (en) 1998-12-16 1998-12-16 Antiparasitic formulations

Publications (1)

Publication Number Publication Date
PA8486601A1 true PA8486601A1 (es) 2000-09-29

Family

ID=10844352

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19998486601A PA8486601A1 (es) 1998-12-16 1999-12-07 Formulaciones antiparasitos

Country Status (21)

Country Link
US (1) US6699847B2 (es)
EP (1) EP1140068B1 (es)
JP (1) JP3848537B2 (es)
AP (1) AP9901699A0 (es)
AR (1) AR019499A1 (es)
AT (1) ATE269074T1 (es)
AU (1) AU762892B2 (es)
BR (1) BR9916265A (es)
CA (1) CA2355102C (es)
DE (1) DE69918165T2 (es)
DK (1) DK1140068T3 (es)
ES (1) ES2221455T3 (es)
GB (1) GB9827727D0 (es)
GT (1) GT199900213A (es)
MA (1) MA26710A1 (es)
PA (1) PA8486601A1 (es)
PE (1) PE20001244A1 (es)
PT (1) PT1140068E (es)
TN (1) TNSN99225A1 (es)
TW (1) TW524691B (es)
WO (1) WO2000035445A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004013142A1 (fr) * 2002-08-02 2004-02-12 The Institute Of Radiation Medicine, Academy Of Miilitary Medical Sciences, People's Liberation Army Derive de riboflavine ainsi que sa fabrication et ses utilisations
AU2003235019A1 (en) * 2003-08-17 2005-03-03 Sirene Call Pty Ltd Attract-and-Kill Method of Controlling Ecto-Parasites from the Order Acarina in Livestock and Domestic Animals as well as Members of the Order Artiodactyle
WO2010008891A2 (en) * 2008-06-24 2010-01-21 Merial Limited Anthelminthic formulations
MX2009001235A (es) * 2008-09-19 2010-04-29 Agrovet Market S A Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina.
JP2012517994A (ja) 2009-02-16 2012-08-09 ファイザー・インク 高投与量ドラメクチン製剤
CN103417477B (zh) * 2012-05-18 2015-08-05 中国农业科学院兰州畜牧与兽药研究所 一种以水为基质的多拉菌素o/w型注射液及其制备方法
WO2014071994A1 (en) 2012-11-09 2014-05-15 Aktiebolaget Electrolux Blender
EA037747B1 (ru) * 2019-04-01 2021-05-18 Севиндж Аллахверди кызы АЛИЕВА Антипаразитарное средство

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL151903B (nl) 1965-03-24 1977-01-17 Schering Ag Werkwijze ter bereiding van een injectievloeistof door een steroid op te lossen in een mengsel van ricinusolie en benzylbenzoaat.
DE3377064D1 (en) 1982-12-28 1988-07-21 Bayer Ag Stable aminoglycoside-penicillin injection formulation
DE3484584D1 (de) 1983-10-14 1991-06-20 Sumitomo Pharma Injektionen mit verzoegerter abgabe.
IL79765A (en) 1985-08-23 1992-02-16 Lilly Co Eli Injectable sustained release formulations of bovine somatotropin
ES2052173T3 (es) 1989-04-11 1994-07-01 Pfizer Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.
NZ234802A (en) 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
ES2131515T3 (es) 1991-09-30 1999-08-01 Merck & Co Inc Formulados inyectables de accion prolongada que contienen aceite de ricino hidrogenado.
DE4410970C1 (de) 1994-03-29 1995-07-20 Talbot Waggonfab Wankstütze für Schienenfahrzeuge mit einer Querneigeeinrichtung
US5580574A (en) 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
CA2233016C (en) * 1995-09-25 2007-07-17 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil

Also Published As

Publication number Publication date
PE20001244A1 (es) 2000-11-07
AU1069900A (en) 2000-07-03
TNSN99225A1 (fr) 2005-11-10
CA2355102A1 (en) 2000-06-22
DE69918165T2 (de) 2004-10-14
AP9901699A0 (en) 2001-05-22
DE69918165D1 (de) 2004-07-22
JP2002532422A (ja) 2002-10-02
CA2355102C (en) 2006-07-11
EP1140068A1 (en) 2001-10-10
AU762892B2 (en) 2003-07-10
PT1140068E (pt) 2004-09-30
EP1140068B1 (en) 2004-06-16
GB9827727D0 (en) 1999-02-10
GT199900213A (es) 2001-06-07
ATE269074T1 (de) 2004-07-15
US6699847B2 (en) 2004-03-02
DK1140068T3 (da) 2004-07-12
ES2221455T3 (es) 2004-12-16
AR019499A1 (es) 2002-02-20
US20020142972A1 (en) 2002-10-03
TW524691B (en) 2003-03-21
BR9916265A (pt) 2001-11-20
JP3848537B2 (ja) 2006-11-22
MA26710A1 (fr) 2004-12-20
WO2000035445A1 (en) 2000-06-22

Similar Documents

Publication Publication Date Title
HN1997000072A (es) Procedimiento para la preparacion de sildenafil
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
TR200002355T2 (tr) 2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri
BR0010220A (pt) Compostos de pirimidinona
ES2163034T3 (es) Composiciones micelares de copolimeros de bloque de polieter, para la objetivizacion de agentes biologicos como diana.
TR200003513T2 (tr) Pirolo[2,3d]Pirimidin kompozisyonları ve kullanımları
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
ATE231872T1 (de) Thiazolopyrimidinderivate
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
DK0915898T3 (da) Krystalform I af clarithromycin
NO20003600L (no) Kalium kanal inhibitorer
DE69914357D1 (de) Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
BR0100982A (pt) Processo para a preparação de derivados deresorcinol
PA8486601A1 (es) Formulaciones antiparasitos
NO20031860D0 (no) Kahalaolid F
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
BR9912916B1 (pt) composição de mistura polimérica, pelìcula, e, artigo de fabricação.
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
GB2324091B (en) Metalloproteinase inhibitors
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
NO20005548L (no) Mykobakterieinhibitorer
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
NO20021309D0 (no) Preparat for IVF